Regulatory News
Tuesday, March 29, 2016
BRIEF-Acelrx Pharmaceuticals names Howard Rosen as CEO
* Acelrx pharmaceuticals names howard b. Rosen as chief
executive officer and provides update on clinical development
activities and corporate priorities for 2016
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment